Filtered By:
Vaccination: Whooping Cough (Pertussis) Vaccine

This page shows you your search results in order of relevance. This is page number 14.

Order by Relevance | Date

Total 1671 results found since Jan 2013.

Association between maternal health literacy and child vaccination in India: a cross-sectional study
Conclusions In these study settings, maternal health literacy is independently associated with child vaccination. Initiatives targeting health literacy could improve vaccination coverage.
Source: Journal of Epidemiology and Community Health - August 11, 2015 Category: Epidemiology Authors: Johri, M., Subramanian, S. V., Sylvestre, M.-P., Dudeja, S., Chandra, D., Kone, G. K., Sharma, J. K., Pahwa, S. Tags: Epidemiologic studies, Cross-sectional studies, Open access, Health promotion Child health Source Type: research

Infection by Bordetella pertussis and bordetella parapertussis in cases of suspected whooping cough (2011-2015) in Mar del Plata, Argentina.
Conclusions: The results show the need to suspect whooping cough and diagnose it early in children, adolescents, and adults in order to better control the disease. Likewise, continuing prevention and containment measures are fundamental in decreasing the circulation of the causal agent. PMID: 28538850 [PubMed - in process]
Source: Revista Peruana de Medicina de Experimental y Salud Publica - May 26, 2017 Category: International Medicine & Public Health Tags: Rev Peru Med Exp Salud Publica Source Type: research

Tdap Vaccination Coverage During Pregnancy - Selected Sites, United States, 2006-2015.
Abstract Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended during the third trimester of each pregnancy to provide protection to newborns, who are at risk for pertussis-related morbidity and mortality (1). As part of its case-control surveillance study of medications and birth defects, the Birth Defects Study of the Slone Epidemiology Center at Boston University (the Birth Defects Study) has recorded data on vaccinations received during pregnancy since 2006. Among 5,606 mothers of infants without structural birth defects in this population (control group), <1% had ...
Source: MMWR Morb Mortal Wkl... - October 20, 2017 Category: Epidemiology Authors: Kerr S, Van Bennekom CM, Liang JL, Mitchell AA Tags: MMWR Morb Mortal Wkly Rep Source Type: research

Pertussis in Africa: Findings and recommendations of the Global Pertussis Initiative (GPI).
Abstract Pertussis remains a major cause of morbidity and mortality, particularly in infants and young children, and despite the availability of vaccines and pertinent national and international guidelines. The disease burden is more severe in low- and middle-income countries (LMICs), especially in the African continent. Pertussis is more prevalent among young infants in Africa. Poor or no pertussis surveillance, lack of disease awareness, diagnostic limitations, and competing health priorities are considered key contributory factors for this high pertussis burden in Africa. Most African countries use whole-cell p...
Source: Vaccine - March 27, 2018 Category: Allergy & Immunology Authors: Muloiwa R, Wolter N, Mupere E, Tan T, Chitkara AJ, Forsyth KD, von König CW, Hussey G Tags: Vaccine Source Type: research

Ethnic group inequalities in coverage with reproductive, maternal and child health interventions: cross-sectional analyses of national surveys in 16 Latin American and Caribbean countries
Publication date: August 2018Source: The Lancet Global Health, Volume 6, Issue 8Author(s): Marilia Arndt Mesenburg, Maria Clara Restrepo-Mendez, Hugo Amigo, Alejandra D Balandrán, Maria Angelica Barbosa-Verdun, Beatriz Caicedo-Velásquez, Liliana Carvajal-Aguirre, Carlos E A Coimbra, Leonardo Z Ferreira, Maria del Pilar Flores-Quispe, Carlos Flores-Ramírez, Giovanna Gatica-Dominguez, Luis Huicho, Karla Jinesta-Campos, Ingrid S K Krishnadath, Fatima S Maia, Ivan A Marquez-Callisaya, Mercedes Marlene Martinez, Oscar J Mujica, Verónica PingraySummaryBackgroundLatin American and Caribbean populations include three main ethn...
Source: The Lancet Global Health - July 14, 2018 Category: International Medicine & Public Health Source Type: research

Midwives' role in the provision of maternal and childhood immunisation information.
CONCLUSION: The provision of immunisation training within midwifery education and continued professional development is critical. Appropriately resourcing midwives with the necessary infrastructure, education and resources to fully inform parents about immunisation may have a positive impact on vaccine uptake. PMID: 30853352 [PubMed - as supplied by publisher]
Source: Women Birth - March 6, 2019 Category: Midwifery Authors: Frawley JE, McKenzie K, Cummins A, Sinclair L, Wardle J, Hall H Tags: Women Birth Source Type: research

Socioeconomic status differences in parental immunization attitudes and child immunization in Canada: Findings from the 2013 Childhood National Immunization Coverage Survey (CNICS)
Publication date: Available online 20 March 2019Source: Preventive MedicineAuthor(s): Richard M. Carpiano, Andrea N. Polonijo, Nicolas Gilbert, Lyne Cantin, Eve DubeAbstractChildhood vaccination efforts in Canada have been negatively impacted by parents' vaccine hesitancy based on their knowledge, attitudes, and beliefs (KAB) about vaccinations. Less understood is the extent to which child vaccination receipt and KAB vary by parents' socioeconomic status (SES). Analyzing different age groups of children and vaccinations, we examine the extent to which (a) family SES (parent education, household income) is a determinant of ...
Source: Preventive Medicine - March 22, 2019 Category: International Medicine & Public Health Source Type: research

Determinants of satisfaction with information and additional information-seeking behaviour for the pertussis vaccination given during pregnancy.
CONCLUSIONS: We found that high trust in health care professionals, a perceived ability to seek out accurate information about vaccines and actively focusing on problems as a means of coping with stress, drives satisfaction in official vaccine information. We also developed measures of these variables that could be used in further research. PMID: 30975566 [PubMed - as supplied by publisher]
Source: Vaccine - April 7, 2019 Category: Allergy & Immunology Authors: Clarke RM, Paterson P, Sirota M Tags: Vaccine Source Type: research

Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review
AbstractInfants are vulnerable to pertussis infection particularly before initiation of pertussis vaccination. Maternal pertussis vaccination during pregnancy has been introduced in a number of countries in order to confer on young infants indirect protection from the disease through transplacental transfer of maternal antibodies. We reviewed the evidence on the immunogenicity and efficacy of maternal pertussis vaccination during pregnancy. A systematic search of PubMed/MEDLINE, EMBASE, Scopus, Cochrane Database of Systematic Reviews, ProQuest, and Science Direct was undertaken to identify studies published between January...
Source: Infectious Diseases and Therapy - September 17, 2019 Category: Infectious Diseases Source Type: research

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
Abstract Three vaccines are recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescents aged 11-12 years to protect against 1) pertussis; 2) meningococcal disease caused by types A, C, W, and Y; and 3) human papillomavirus (HPV)-associated cancers (1). At age 16 years, a booster dose of quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended. Persons aged 16-23 years can receive serogroup B meningococcal vaccine (MenB), if determined to be appropriate through shared clinical decision-making. CDC analyzed data from the 2019 National Immunization Survey...
Source: MMWR Morb Mortal Wkl... - August 20, 2020 Category: Epidemiology Authors: Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, Fredua B, McNamara L, Stokley S Tags: MMWR Morb Mortal Wkly Rep Source Type: research

Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
Emerg Infect Dis. 2021 Jun;27(6):1561-1566. doi: 10.3201/eid2706.203850.ABSTRACTRecent reemergence of pertussis (whooping cough) in highly vaccinated populations and rapid expansion of Bordetella pertussis strains lacking pertactin (PRN), a common acellular vaccine antigen, have raised the specter of vaccine-driven evolution and potential return of what was once the major killer of children. The discovery that most circulating B. pertussis strains in the United States have acquired new and independent disruptive mutations in PRN is compelling evidence of strong selective pressure. However, the other 4 antigens included in ...
Source: Emerging Infectious Diseases - May 20, 2021 Category: Infectious Diseases Authors: Longhuan Ma Amanda Caulfield Kalyan K Dewan Eric T Harvill Source Type: research

Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review
CONCLUSIONS: A body of literature is available from which to plan and design future studies of vaccination in pregnant women using RWD. This is of intense importance as new vaccines, such as those for COVID-19, become available to the general population via approval or authorization without inclusion of pregnant women in the clinical trials.PMID:34090699 | DOI:10.1016/j.vaccine.2021.05.071
Source: Vaccine - June 6, 2021 Category: Allergy & Immunology Authors: Tamar Lasky Ann W McMahon Wei Hua Richard Forshee Source Type: research

Hexavalent vaccines: What can we learn from head-to-head studies?
CONCLUSION: Although the licensed hexavalent vaccines are generally considered similar, analyses of immunogenicity data from head-to-head trials highlighted differences that could be related to differences in composition and formulation. In addition, the demonstrated non-inferiority of the immunogenicity of the more recent vaccines versus DT3aP-HBV-IPV/Hib does not allow a full bridging to similar efficacy, effectiveness and safety. The availability of DT3aP-HBV-IPV/Hib over > 20 years allowed to collect a wealth of data on its long-term immunogenicity, safety and effectiveness in clinical and post-marketing studies, an...
Source: Vaccine - September 17, 2021 Category: Allergy & Immunology Authors: Markus Knuf Herv é Haas Pilar Garcia-Corbeira Elisa Turriani Piyali Mukherjee Winnie Janssens Val érie Berlaimont Source Type: research

Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools. As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Health - November 1, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news